DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target.

"Declarations Ethics approval and consent to participateThe experimental procedures involving mice were conducted in accordance with the guidelines of the Institutional Animal Care and Use Committee (IACUC) of the Sun Yat-sen University Cancer Center. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding This work was carried out with the supports of the National Natural Science Foundation of China (81872499; 82303657), China Postdoctoral Science Foundation (2022MD713734), Natural Science Foundation of Guangxi (2023GXNSFBA026245) and Health Commission of Guangxi Zhuang Autonomous Region (S2021018)."